These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3771721)

  • 1. Determination of atenolol in plasma by high-performance liquid chromatography with application to single-dose pharmacokinetics.
    Miller LG; Greenblatt DJ
    J Chromatogr; 1986 Aug; 381(1):201-4. PubMed ID: 3771721
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of atenolol in human plasma by HPLC with fluorescence detection: validation and application in a pharmacokinetic study.
    Spanakis M; Niopas I
    J Chromatogr Sci; 2013 Feb; 51(2):128-32. PubMed ID: 22729617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of serum atenolol using HPLC with fluorescence detection following isolation with activated charcoal.
    Alebić-Kolbah T; Plavsić F; Wolf-Coporda A
    J Pharm Biomed Anal; 1989; 7(12):1777-81. PubMed ID: 2490566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC method for determination of atenolol in human plasma and application to a pharmacokinetic study in Turkey.
    Yilmaz B; Arslan S; Asci A
    J Chromatogr Sci; 2012; 50(10):914-9. PubMed ID: 22718748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atenolol determination by high-performance liquid chromatography and fluorescence detection.
    Yee YG; Rubin P; Blaschke TF
    J Chromatogr; 1979 Apr; 171():357-62. PubMed ID: 546856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of atenolol in human plasma using ionic-liquid-based ultrasound-assisted in situ solvent formation microextraction followed by high-performance liquid chromatography.
    Zeeb M; Farahani H; Papan MK
    J Sep Sci; 2016 Jun; 39(11):2138-45. PubMed ID: 27061492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of biological equivalence of two atenolol preparations.
    Wolf-Coporda A; Plavsić F; Vrhovac B
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):567-71. PubMed ID: 3323073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid determination of atenolol in human plasma and urine by high-pressure liquid chromatography.
    Weddle OH; Amick EN; Mason WD
    J Pharm Sci; 1978 Jul; 67(7):1033-5. PubMed ID: 660497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of the enantiomers of atenolol.
    Boyd RA; Chin SK; Don-Pedro O; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Apr; 45(4):403-10. PubMed ID: 2702798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
    Bühring KU; Garbe A
    J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
    Telatyńska-Smieszek B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
    Pol Arch Med Wewn; 2004 Jan; 111(1):45-51. PubMed ID: 15088420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantification of atenolol and chlorthalidone in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
    Shah JV; Patel DP; Shah PA; Sanyal M; Shrivastav PS
    Biomed Chromatogr; 2016 Feb; 30(2):208-16. PubMed ID: 26096961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple and rapid analysis of atenolol and metoprolol in plasma using solid-phase extraction and high-performance liquid chromatography.
    Harrison PM; Tonkin AM; McLean AJ
    J Chromatogr; 1985 May; 339(2):429-33. PubMed ID: 4008584
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversed-phase high-performance liquid chromatographic analysis of atenolol enantiomers in plasma after chiral derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate.
    Rosseel MT; Vermeulen AM; Belpaire FM
    J Chromatogr; 1991 Jul; 568(1):239-45. PubMed ID: 1770102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and absolute bioavailability of atenolol.
    Mason WD; Winer N; Kochak G; Cohen I; Bell R
    Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid high-performance liquid chromatographic method for the measurement of atenolol in plasma using UV detection.
    Verghese C; McLeod A; Shand D
    J Chromatogr; 1983 Jul; 275(2):367-75. PubMed ID: 6619241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct enantiospecific HPLC bioanalysis of (R,S)-atenolol on a chiral stationary phase.
    Kofahl B; Henke D; Mutschler E
    Chirality; 1993; 5(6):479-82. PubMed ID: 8398605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol.
    Carmona MJ; Pereira VA; Malbouisson LM; Auler JO; Santos SR
    Braz J Med Biol Res; 2009 Jun; 42(6):574-81. PubMed ID: 19448909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence of two tablet formulations of atenolol after single oral administration in healthy volunteers.
    Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N; Njau SN
    Arzneimittelforschung; 2000 Mar; 50(3):243-7. PubMed ID: 10758775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination in biologic media of a new beta-blocker, atenolol, by high performance liquid chromatography].
    Decourt S; Flouvat B
    J Chromatogr; 1979 Jun; 174(1):258-63. PubMed ID: 546890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.